Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Curocell Inc.

Clinical trials sponsored by Curocell Inc., explained in plain language.

Curocell Inc. 372320 KOSDAQ

Cell therapy biotech developing CAR-T treatments for cancer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

Experimental CAR-T therapy takes aim at Hard-to-Treat lupus kidney disease

Disease control Not yet recruiting

This early-phase trial is testing a new treatment called CRC01 for people with severe lupus nephritis, a serious kidney complication of lupus. The therapy uses a patient's own immune cells, which are modified in a lab to target and destroy certain immune cells that drive the dise…

Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC